CLINICAL_TRIALS
trial_result
· 2014-02-28
Clinical Trial Update: Sapropterin as a Treatment for Autistic Disorder [Phase 2]
Summary
A Phase 2 clinical trial evaluating sapropterin as a treatment for autism spectrum disorder has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Children's Health Council | Conditions: Autistic Disorder | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28